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Objective: Systemic hypertension is common in patients after bidirectional superior
cavopulmonary connection. It can be treated with a vasodilator, such as sodium
nitroprusside. However, it is possible that systemic hypertension is necessary to
maintain cerebral blood flow in the face of cerebral venous hypertension. Further-
more, bidirectional superior cavopulmonary connection places the cerebral and
pulmonary vascular beds in series. Thus treatment of systemic hypertension by
lowering blood pressure might decrease cerebral blood flow, pulmonary blood flow,
and systemic oxygen levels. The aim of the current study was to determine the
effects of sodium nitroprusside on cerebral blood flow velocity and systemic
oxygenation in patients after bidirectional superior cavopulmonary connection.
Methods: This is a prospective patient-controlled study of 9 patients (median age, 7
months; age range, 4 to 12 months) undergoing bidirectional superior cavopulmo-
nary connection. Patients were studied in the intensive care unit within 6 hours of
surgical intervention while sedated, paralyzed, and mechanically ventilated. Sodium
nitroprusside was infused to achieve a decrease in mean systemic blood pressure of
approximately 20%. Cerebral blood flow velocity was measured by means of
transcranial Doppler ultrasonography of the middle cerebral artery.
Results: During sodium nitroprusside infusion, mean systemic blood pressure de-
creased (from 69  6 mm Hg at baseline to 58  6 mm Hg, P  .05). However,
there was no accompanying change in 2 indicators of cerebral blood flow: blood
flow velocity in the middle cerebral artery and arteriovenous oxygen saturation
difference across the upper body. Both arterial PO2 and systemic oxygen saturation
were also preserved during sodium nitroprusside infusion.
Conclusions: Sodium nitroprusside decreases systemic blood pressure in patients
after bidirectional superior cavopulmonary connection. This decrease occurs with-
out accompanying changes in cerebral blood flow velocity or systemic oxygen
levels. These findings suggest that cerebral and pulmonary blood flows are pre-
served during sodium nitroprusside infusion. Sodium nitroprusside appears to be an
appropriate agent for the treatment of systemic hypertension after bidirectional
superior cavopulmonary connection.
Bidirectional superior cavopulmonary connection (BSCC) is widelyused in patients with functional single ventricles. The postoperativecourse after BSCC is frequently characterized by systemic hyper-tension, which can be treated with a vasodilator, such as sodiumnitroprusside.1 The cause of systemic hypertension after BSCC isunknown. BSCC increases superior vena caval pressure and there-
fore cerebral venous pressure. It is possible that systemic hypertension is necessary
to maintain the transcerebral pressure gradient and therefore cerebral blood flow in
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the face of cerebral venous hypertension. Treatment of
systemic hypertension by lowering blood pressure might
then decrease cerebral blood flow. The effect of lowering
blood pressure after BSCC on cerebral blood flow has not
been previously examined.
Furthermore, BSCC places the cerebral and pulmonary
vascular beds in series. Previous studies have shown that
after BSCC, interventions that alter cerebral blood flow,
such as hyperventilation and hypoventilation, also alter pul-
monary blood flow and systemic oxygenation.2,3 Thus treat-
ment of systemic hypertension might decrease not just ce-
rebral blood flow but also pulmonary flow and systemic
oxygen levels. The aim of the current study was to deter-
mine the effects of sodium nitroprusside on cerebral blood
flow velocity and systemic oxygenation in patients after
BSCC.
Methods
Patients
This study was approved by the Institutional Review Board of the
Medical University of South Carolina; informed consent was ob-
tained for all patients. Nine patients undergoing BSCC were pro-
spectively studied. The median patient age was 7 months (range,
4-12 months), and the median weight was 7.0 kg (range, 4.9-10.0
kg). There were 4 male and 5 female patients. Diagnoses were
hypoplastic left heart syndrome (3), double-inlet left ventricle (2),
tricuspid atresia (1), double-outlet right ventricle with mitral atre-
sia (1), pulmonary atresia with intact ventricular septum (1), and
crisscross heart with straddling atrioventricular valves (1). Previ-
ous operations were a Norwood procedure in 5 patients, modified
Blalock-Taussig shunt placement in 3 patients, and none in 1
patient. At preoperative cardiac catheterization in 8 patients, pul-
monary venous wedge pressure was 16  4 mm Hg, transpulmo-
nary gradient was 7  1 mm Hg, and pulmonary vascular resis-
tance was 2.0  0.4 units/m2. No patient had significant
aortopulmonary collaterals identified at preoperative angiography.
Surgical Techniques
BSCC consisted of a bidirectional Glenn shunt in 8 patients and a
hemi-Fontan procedure in 1 patient.1,4-6 All systemic to pulmonary
shunts were divided at the time of BSCC; therefore the BSCC
provided the only source of pulmonary blood flow in all patients.
Concomitant procedures included pulmonary arterioplasty in 5
patients, atrial septectomy in 4 patients, aortic valve repair in 1
patient, and innominate artery reimplantation in 1 patient. All
operations were performed through a median sternotomy and used
cardiopulmonary bypass (144  49 minutes). Myocardial car-
dioplegic arrest was used in 6 patients (28  15 minutes), and
circulatory arrest was used in 4 patients (16  6 minutes).
Study Protocol
All patients were studied in the pediatric cardiac intensive care unit
within 6 hours of surgical intervention while sedated (fentanyl, 20
g · kg1 · h1), paralyzed (vecuronium, 0.1 mg · kg1 · h1), and
mechanically ventilated. At the time of the study, all patients were
receiving milrinone infusions (0.5-0.75 g · kg1 · min1); 5 were
also receiving dopamine infusions (3-10 g · kg1 · min1). All
infusions were maintained at constant rates, and no blood transfu-
sions were given during the study. Three of the 9 patients received
a single bolus of 5% albumin (5 mL/kg) during the protocol. All
patients were in normal sinus rhythm throughout the study. Pa-
tients were mechanically ventilated with a Servo 300 ventilator
(Siemens-Elema AB, Solna, Sweden) in pressure-regulated vol-
ume control mode. The fraction of inspired oxygen was set at 1.0,
peak end-expiratory pressure at 0 cm H2O, and tidal volume at 14
to 18 mL/kg; the ventilator rate was adjusted to achieve a normal
pH and PCO2.
Patients were studied at baseline (time 1), during sodium ni-
troprusside infusion (time 2), and after return to baseline (time 3).
Sodium nitroprusside was titrated to achieve a decrease in the
mean arterial blood pressure of approximately 20% (median dose,
3 g · kg1 · min1; range, 1-4 g · kg1 · min1). Once the target
blood pressure was obtained, sodium nitroprusside was continued
for a 15-minute stabilization period before determination of arte-
rial blood gas, hemodynamic, and transcranial cerebral Doppler
values. Arterial blood gases were obtained from samples drawn
from radial or femoral arterial catheters. Systemic oxygen satura-
tion was measured by means of extremity oximetry (Hewlett-
Packard Co, Palo Alto, Calif). Common atrial and pulmonary
artery pressures were measured through transthoracic lines placed
in the operating room. The transpulmonary gradient was derived as
pulmonary artery pressure minus common atrial pressure. Pulmo-
nary artery oxygen saturation was determined from samples from
the pulmonary artery line. The upper body arteriovenous oxygen
saturation difference was derived as the systemic minus the supe-
rior vena caval (pulmonary artery) oxygen saturation.
Cerebral blood flow velocity was determined by means of
transcranial Doppler ultrasonography of the middle cerebral artery
by using a temporal window. The middle cerebral artery was
identified by means of color flow Doppler ultrasonography and a
maximum signal recorded from the M1 segment by using a 4-MHz
transducer. The time-averaged maximum velocity acquired over a
1-minute period was used for analysis. Studies were performed
with either an Acuson 128 or Acuson Sequoia machine (Siemens).
Statistics
Data are shown as means  SD. Comparison of the 3 time points
in the study protocol was by means of repeated-measures analysis
of variance. Multiple comparison testing was done with paired t
tests with the Bonferroni correction. In our 2 previous studies of
infants after BSCC, changes in ventilation (hyperventilation or
hypoventilation) produced changes of 27% to 49% from baseline
in cerebral flow velocity and of 20 to 35% in systemic PO2.2,3 On
the basis of those studies, we considered a change of at least 30%
from baseline cerebral flow velocity and at least 20% from base-
line systemic PO2 to be important. Sample size calculations indi-
cated that a sample size of 8 patients would be required to show
such differences from the baseline values in this study, with an 
value of .05 and a  value of .2 (power of 80%).
Results
Sodium nitroprusside lowered systemic blood pressure but
had no significant effect on other hemodynamic parameters
(Table 1). During infusion of sodium nitroprusside, mean
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systemic blood pressure decreased from 69  6 to 58  6
mm Hg (P  .05). This decrease was not accompanied by
changes in pulmonary artery pressure, common atrial pres-
sure, transpulmonary gradient, or heart rate.
At baseline, the arterial PO2 value was 49  12 mm Hg,
and systemic oxygen saturation was 84%  7% (Table 2).
Sodium nitroprusside infusion had no significant effect on
either measure of systemic oxygenation (Table 2).
Two indicators of cerebral blood flow were examined:
blood flow velocity in the middle cerebral artery and arte-
riovenous oxygen saturation difference across the upper
body. At baseline, flow velocity in the middle cerebral
artery was 54  16 cm/s, and the upper body arteriovenous
oxygen saturation difference was 32%  9%. Neither pa-
rameter changed during infusion of sodium nitroprusside
(Table 3).
Discussion
Systemic hypertension is frequently observed after BSCC.
Chang and colleagues1 reviewed the postoperative course
and early results of BSCC in young infants at Children’s
Hospital, Boston. They found systolic hypertension in 88%
of their patients. One half of those were treated with a
vasodilator (either sodium nitroprusside or amrinone). The
severity of systolic hypertension decreased in all patients
after the first 24 postoperative hours. However, almost 50%
were discharged from the hospital on a regimen of antihy-
pertensive medication.
The cause of systemic hypertension after BSCC is un-
known. Potential contributing factors are postoperative pain
and issues unique to the BSCC, such as hormone levels,
altered ventricular geometry, and increased cerebral venous
pressure. Increased levels of antidiuretic hormone, cortisol,
and aldosterone have been documented in the first day after
BSCC.7 Increases in antidiuretic hormone, angiotensin II,
renin, and atrial natriuretic factor have also been observed
late (2 years) after BSCC.8 Increases in these or other
hormones could contribute to systemic hypertension. After
BSCC, reduction in ventricular volume load results in al-
tered ventricular geometry. This is characterized by an acute
decrease in ventricular end-diastolic volume and an increase
in wall thickness.9 It is also possible that altered ventricular
geometry and ejection characteristics could contribute to
systemic hypertension.
A third issue unique to the BSCC is cerebral venous
hypertension. By connecting the superior vena cava to the
pulmonary arteries, BSCC results in increased superior vena
caval pressure and therefore cerebral venous pressure. It has
been hypothesized that systemic hypertension is a compen-
satory reflex aimed at maintaining transcerebral pressure
gradient and cerebral blood flow in the face of cerebral
venous hypertension.1 If this hypothesis is correct, treating
systemic hypertension after BSCC by lowering blood pres-
sure could decrease cerebral blood flow. The effect of
lowering blood pressure after BSCC on cerebral blood flow
has not been previously examined.
In the current study sodium nitroprusside had no signif-
icant effect on 2 indicators of cerebral blood flow, cerebral
blood flow velocity in the middle cerebral artery and upper
body arteriovenous oxygen saturation difference. The va-
lidity of using middle cerebral artery flow velocity as an
indicator of cerebral blood flow has been previously dis-
cussed.2,3,10 Because flow through a vessel is equal to mean
flow velocity multiplied by cross-sectional area, changes in
flow velocity reflect changes in flow as long as the vessel
TABLE 1. Hemodynamic parameters
Time 1:
Baseline
Time 2: Sodium
nitroprusside
Time 3:
Baseline
Systemic blood
pressure (mm Hg)
Systolic 98 9 84 11* 98 7
Diastolic 53 5 46 7* 53 6
Mean 69 6 58 6* 68 6
Pulmonary artery
pressure (mm Hg)
13 2 12 2 13 2
Common atrial
pressure (mm Hg)
7 1 6 1 7 1
Transpulmonary
gradient (mm Hg)
6 2 6 2 6 2
Heart rate
(beats/min)
142 14 143 13 141 12
*P  .05 vs. baseline (analysis of variance).
TABLE 2. Arterial blood gas values
Time 1:
Baseline
Time 2: Sodium
nitroprusside
Time 3:
Baseline
PO2 (mm Hg) 49 12 47 9 45 10
PCO2 (mm Hg) 41 4 40 5 41 6
pH 7.40 0.03 7.40 0.05 7.40 0.1
Bicarbonate
(mmol/L)
25 2 24 2 25 2
Systemic oxygen
saturation (%)
84 7 81 6 81 8
TABLE 3. Cerebral blood flow indicators
Time 1:
Baseline
Time 2: Sodium
nitroprusside
Time 3:
Baseline
Middle cerebral artery
flow velocity (cm/s)
54 16 54 11 58 18
Upper body
arteriovenous
oxygen saturation
difference (%)
32 9 33 9 33 8
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diameter does not change. In children during cardiopulmo-
nary bypass, the diameter of the middle cerebral artery has
been found to remain constant as blood pressure changes.11
Furthermore, changes in middle cerebral artery flow veloc-
ity correlate with changes in cerebral flow, as measured on
the basis of internal carotid artery flow volume,12 the Kety-
Schmidt method,13 and xenon washout techniques.10,14 Cor-
relation with xenon washout has been found both during and
after hypothermic cardiopulmonary bypass.14 Transcranial
Doppler ultrasonography of the middle cerebral artery is
also an extremely sensitive method of detecting cerebral
blood flow. During low-flow cardiopulmonary bypass in
children, transcranial Doppler ultrasonography has been
shown to detect middle cerebral artery flow, with reduction
of the bypass pump flow as low as 30 mL/kg.15,16 In the
present study blood flow velocity in the middle cerebral
artery was unchanged during sodium nitroprusside infusion.
The absolute flow velocities measured were similar to those
seen in previous studies of pediatric patients after cardio-
pulmonary bypass.2,3,16 Thus the current findings are in line
with those of previous studies and suggest that cerebral
blood flow did not change during sodium nitroprusside
infusion.
The second indicator of cerebral blood flow used in the
current study was arteriovenous oxygen saturation differ-
ence across the upper body. By using the Fick principle, a
decrease in cerebral and upper body blood flow would be
expected to result in an increase in the upper body arterio-
venous oxygen saturation difference. This difference did not
change in our patients during sodium nitroprusside infusion.
This finding is further consistent with preservation of cere-
bral blood flow during sodium nitroprusside infusion. It is
also in agreement with the results of other studies that found
no change in cerebral blood flow during infusion of nitro-
prusside in human subjects during sedation or anesthe-
sia.17,18 BSCC provides pulmonary blood flow by connect-
ing the superior vena cava to the pulmonary arteries. This
connection places the cerebral and pulmonary vascular beds
in series. Alterations in cerebral blood flow might therefore
be expected to affect pulmonary blood flow and systemic
oxygen levels in patients with a BSCC. In previous studies
we found that alterations in arterial PCO2, which are known
to affect cerebral blood flow,19 do affect systemic oxygen-
ation after BSCC.2,3 Hyperventilation, which produces hy-
pocarbia, reduced both flow velocity in the middle cerebral
artery and systemic PO2 in patients after BSCC.2 Con-
versely, hypoventilation increased both middle cerebral ar-
tery flow velocity and systemic oxygenation.3 This linkage
of cerebral and pulmonary blood flow raises the possibility
that lowering blood pressure after BSCC might impair not
just cerebral but also pulmonary blood flow. In the presence
of intracardiac mixing of systemic and pulmonary venous
return, as occurs after BSCC, decreased pulmonary blood
flow will result in decreased systemic oxygen levels.
In the current study sodium nitroprusside had no signif-
icant effect on systemic oxygenation. Neither systemic PO2
nor oxygen saturation changed when systemic blood pres-
sure was decreased by nitroprusside. This suggests that
pulmonary blood flow, along with cerebral blood flow, was
preserved during sodium nitroprusside infusion. This infor-
mation might be particularly useful in the management of
patients who are hypoxemic after BSCC5,20,21: a vasodilator
can be used to treat systemic hypertension without further
compromising systemic oxygenation.
In our study patients sodium nitroprusside effectively
reduced systemic blood pressure without causing other he-
modynamic alterations. Systemic hypertension after cardiac
surgery is undesirable for several reasons. Increased blood
pressure can contribute to postoperative bleeding. It also
increases ventricular afterload, which has the potential to
decrease cardiac output. Increased ventricular afterload
might be particularly undesirable in patients with decreased
ventricular function caused by myocardial stunning early
after cardiac surgery and in patients with single-ventricle
palliation rather than biventricular repair. Our results sug-
gest that sodium nitroprusside is an effective and safe treat-
ment for systemic hypertension early after BSCC.
The current study was prospective and patient-con-
trolled. Respiratory and cardiac variables, including ino-
trope delivery, were controlled so as to isolate the effects of
sodium nitroprusside infusion. A limitation of the study is
the small number of patients. However, because of the study
design, in which each patient served as his or her own
control subject, this number of patients would have allowed
us to detect changes of 30% from baseline cerebral flow
velocity and of 20% from baseline systemic PO2 with a
power of 80%. These changes are equivalent to those ob-
served in our 2 previous studies of infants after BSCC.2,3 It
remains possible that changes of smaller magnitude could
have occurred during sodium nitroprusside infusion but not
been detected in this study. A further study limitation is that
neither cerebral nor pulmonary blood flow was directly
measured because such measurements are difficult in infants
early after cardiac surgery. Conditions of sedation and pa-
ralysis were used to eliminate spontaneous respiration and
minimize response to stimulation, and all patients were
receiving milrinone infusions at the time of the study.
Whether these results would also apply in patients who were
spontaneously ventilating or not already receiving a vaso-
dilator would require further study.
In summary, sodium nitroprusside decreases systemic
blood pressure in patients after BSCC. This decrease occurs
without accompanying changes in cerebral blood flow ve-
locity or systemic oxygen levels. These findings suggest
that both cerebral and pulmonary blood flow are preserved
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during sodium nitroprusside infusion. Thus sodium nitro-
prusside appears to be an appropriate agent for the treatment
of systemic hypertension after BSCC.
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